热门资讯> 正文
ADC Therapeutics申请通过出售股东出售2773万股普通股
2025-07-01 05:36
- ADC Therapeutics (NYSE:ADCT) filed a prospectus to sale 27.73 million shares of common stock.
- The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder.
- This prospectus is not an offer to sell.
- Filing
More on ADC Therapeutics
- ADC reports data from lymphoma trial, streamlines operations
- ADC Therapeutics announces $100M private financing
- Seeking Alpha’s Quant Rating on ADC Therapeutics
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。